PlainRecalls
FDA Drug Moderate Class II Ongoing

Bicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units per 4 mL, 4ml-vial, Rx Only, Distributed by Pfizer Inc., New York, NY 10001, Made in Austria, Carton NDC- 60793-702-10 , Syringe NDC-60793-702-04

Reported: August 6, 2025 Initiated: July 10, 2025 #D-0545-2025

Product Description

Bicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units per 4 mL, 4ml-vial, Rx Only, Distributed by Pfizer Inc., New York, NY 10001, Made in Austria, Carton NDC- 60793-702-10 , Syringe NDC-60793-702-04

Reason for Recall

CGMP Deviations; particulates identified during visual inspection

Details

Recalling Firm
Pfizer Inc.
Units Affected
19,279 vials
Distribution
Nationwide in the USA
Location
New York, NY

Frequently Asked Questions

What product was recalled?
Bicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units per 4 mL, 4ml-vial, Rx Only, Distributed by Pfizer Inc., New York, NY 10001, Made in Austria, Carton NDC- 60793-702-10 , Syringe NDC-60793-702-04. Recalled by Pfizer Inc.. Units affected: 19,279 vials.
Why was this product recalled?
CGMP Deviations; particulates identified during visual inspection
Which agency issued this recall?
This recall was issued by the FDA Drug on August 6, 2025. Severity: Moderate. Recall number: D-0545-2025.